Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM

R Fuleihan, N Ramesh, R Loh, H Jabara, R S Rosen, T Chatila, S M Fu, I Stamenkovic, R S Geha, R Fuleihan, N Ramesh, R Loh, H Jabara, R S Rosen, T Chatila, S M Fu, I Stamenkovic, R S Geha

Abstract

B lymphocytes from patients with X chromosome-linked immunoglobulin deficiency with normal or elevated serum IgM are unable to switch from the synthesis of IgM/IgD to that of other immunoglobulin isotypes. Isotype switch recombination was evaluated in three affected males by examining interleukin 4-driven IgE synthesis. T-cell-dependent IgE synthesis was completely absent in the B lymphocytes of the patients. In contrast, CD40 mAb plus interleukin 4 induced the patients' B cells to synthesize IgE and to undergo deletional switch recombination. Because interaction between CD40 and its ligand on activated T cells is critical for T-cell-driven isotype switching, we examined CD40 ligand expression. In contrast to normal T cells, lymphocytes from the patients expressed no detectable CD40 ligand on their surface after stimulation with phorbol 12-myristate 13-acetate and ionomycin, although the mRNA of the ligand was expressed normally. These results suggest that defective expression of the CD40 ligand underlies the failure of isotype switching in this disease.

References

    1. J Clin Invest. 1979 Aug;64(2):385-91
    1. Cell. 1990 Jun 29;61(7):1303-13
    1. J Exp Med. 1982 Mar 1;155(3):839-51
    1. Scand J Immunol. 1981 Nov;14(5):449-57
    1. J Clin Invest. 1983 Nov;72(5):1650-7
    1. N Engl J Med. 1986 Feb 13;314(7):409-13
    1. Anal Biochem. 1987 Apr;162(1):156-9
    1. Cell. 1989 Mar 24;56(6):1057-62
    1. J Exp Med. 1989 Apr 1;169(4):1295-307
    1. J Immunol. 1990 Nov 15;145(10):3468-73
    1. Eur J Immunol. 1990 Dec;20(12):2603-8
    1. J Immunol. 1991 Sep 1;147(5):1557-60
    1. J Allergy Clin Immunol. 1991 Sep;88(3 Pt 1):285-95
    1. J Exp Med. 1992 Jan 1;175(1):289-92
    1. J Immunol. 1992 Mar 1;148(5):1315-21
    1. Nature. 1992 May 7;357(6373):80-2
    1. J Immunol. 1992 Jul 15;149(2):655-60
    1. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6550-4
    1. EMBO J. 1992 Dec;11(12):4313-21
    1. J Immunol. 1989 Jun 15;142(12):4144-52
    1. EMBO J. 1989 May;8(5):1403-10
    1. J Immunol. 1990 Jan 15;144(2):570-3
    1. Annu Rev Immunol. 1990;8:717-35
    1. Clin Immunol Immunopathol. 1981 Oct;21(1):50-61

Source: PubMed

Подписаться